How are liquid biopsies changing cancer diagnostics?
Liquid biopsies represent a non-invasive alternative to traditional tissue biopsies. By analyzing circulating tumor DNA (ctDNA) in the blood, liquid biopsies can detect cancer at an early stage, monitor treatment response, and identify potential relapses. This technology offers a less painful and quicker method for cancer detection, making it easier for both patients and healthcare providers to manage the disease.
